Sign Up Today and Learn More About Slingshot Biosciences Stock
Invest in or calculate the value of your shares in Slingshot Biosciences or other pre-IPO companies through EquityZen's platform.
Slingshot Biosciences Stock (SLBI)
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
About Slingshot Biosciences Stock
Founded
2012
Headquarters
Emeryville, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Slingshot Biosciences Press Mentions
Stay in the know about the latest news on Slingshot Biosciences
Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays
businesswire • May 06, 2025
Cd34 stem cell mimics
patents • May 04, 2025
Engineered particles as red blood cell mimics and compositions containing same …
patents • Apr 02, 2025
Hydrogel particles as feeder cells and as synthetic antigen presenting cells
patents • Apr 02, 2025
Apoptotic cell mimic
patents • Apr 02, 2025
Slingshot Biosciences Management
Leadership team at Slingshot Biosciences
Co-Founder, CEO, and President
Jeff Kim
Board Member
William (Bill) Hyun
Join now and verify your accreditation status to gain access to:
- Slingshot Biosciences Current Valuation
- Slingshot Biosciences Stock Price
- Slingshot Biosciences Management
- Available deals in Slingshot Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Slingshot Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Slingshot Biosciences Revenue and Financials
- Slingshot Biosciences Highlights
- Slingshot Biosciences Business Model
- Slingshot Biosciences Risk Factors
- Slingshot Biosciences Research Report from SACRA Research
Trading Slingshot Biosciences Stock
How to invest in Slingshot Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Slingshot Biosciences through EquityZen funds. These investments are made available by existing Slingshot Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Slingshot Biosciences stock?
Shareholders can sell their Slingshot Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
